Compound ID | 649
PF-02341752
Class: Oxazolidinone
| Spectrum of activity: | Gram-negative |
| Details of activity: | Developed to treat infections caused by susceptible and MDR Gram-positive bacteria which was demonstrated to be the case in mouse models |
| Description: | Penzien JB. In Vitro and In Vivo Activity of PF-00708093 and PF-02341752: New Oxazolidinone Antibacterials versus Recent Bacterial Clinical Isolates. 49th-ICAAC 2009 |
| Institute where first reported: | Pfizer, US |
| Year first mentioned: | 2009 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.